Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60.

Saved in:
Bibliographic Details
Title: Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60.
Authors: Egeberg, Alexander1,2 (AUTHOR) alexander.egeberg@gmail.com, Hawkes, Jason E.3 (AUTHOR), Somani, Najwa4 (AUTHOR), Burge, Russel4,5 (AUTHOR), See, Kyoungah4 (AUTHOR), Gallo, Gaia4 (AUTHOR), McKean-Matthews, Missy6 (AUTHOR), Gooderham, Melinda7 (AUTHOR), Han, George8 (AUTHOR), Armstrong, April9 (AUTHOR)
Source: Dermatology & Therapy. Apr2024, Vol. 14 Issue 4, p1007-1018. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-024-01147-7